PA
Phibro Animal Health Corporation
PAHC · NASDAQ
$35.62 -4.78% (-$1.79)
1M +4.58%
Market Cap $1.48B
P/E Ratio 14.87x
Div. Yield 1.31%
ROE 28.67%
Bulios Fair Price
$47.33
32.9% upside
Trenutna cena
$35.62
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PAHC trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
63 /100
Fair EV/EBITDA 8.51x
P/S 0.98x
P/B 3.85x
Growth
94 /100
Growing Rev. growth 15.79%
Book val. growth 10.91%
EPS growth 44.42%
Profitability
41 /100
Moderate Net margin 6.57%
Op. margin 13.07%
FCF margin 0.65%
Quality
78 /100
Excellent ROE 28.67%
ROA 6.64%
Asset turnover 1.01x
Debt
54 /100
Moderate Current ratio 2.96x
Int. coverage 3.89x
Net debt/EBITDA 2.24x
Stability
57 /100
Moderate Rev. volatility 11.68%
EPS volatility 1,088.24%
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PAHC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Daniel Bendheim
Employees
2,605
Headquarters
Teaneck
Prihajajoči dogodki
04 NOV.
Earnings
Upcoming earnings report